Fortis Healthcare Schedules Board Meeting for Q2 Earnings and Debenture Terms Alteration
Fortis Healthcare Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Fortis Healthcare Schedules Board Meeting for Q2 Earnings and Debenture Terms Alteration Fortis Healthcare's Board of Directors will meet on 5th Nov'26 to consider and approve standalone and consolidated un-audited financial results for the quarter and half-year ended 30th Sep'26. The board will also evaluate alterations to the rights, interest payment dates, and terms for 155,000 listed, senior, unsecured, rated, redeemable Non-Convertible Debentures aggregating up to INR 1,550 crore (face value INR 1,00,000 each). Consequently, the insider trading window remains closed until 7th Nov'26.
Original exchange filing (PDF)
More announcements from Fortis Healthcare Ltd
- Relevant disclosure is attached 路 10 Nov 2026
- Relevant Disclosure is attached 路 06 Nov 2026
- The relevant disclosure is attached 路 06 Nov 2026
- The relevant disclosure is attached 路 06 Nov 2026
- The relevant disclosure is attached 路 06 Nov 2026
- The relevant disclosure is attached 路 05 Nov 2026
- Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- The relevant disclosure is attached 路 05 Nov 2026
